Patent details
EP1420799 Title: USE OF ATAZANAVIR IN HIV THERAPY
Basic Information
- Publication number:
- EP1420799
- PCT Application Number:
- PCT/US/2002/026675
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP027977446
- PCT Publication Number:
- WO/2003/020206
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF ATAZANAVIR IN HIV THERAPY
- French Title of Invention:
- UTILISATION D'ATAZANAVIR EN THERAPIE VIH
- German Title of Invention:
- VERWENDUNG VON ATAZANAVIR IN DER HIV-THERAPIE
- SPC Number:
Dates
- Filing date:
- 21/08/2002
- Grant date:
- 04/10/2006
- EP Publication Date:
- 04/10/2006
- PCT Publication Date:
- 13/03/2003
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/05/2004
- EP B1 Publication Date:
- 04/10/2006
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 21/08/2008
- Expiration date:
- 21/08/2022
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/08/2002
- Name:
- Bristol-Myers Squibb Company
- Address:
- P.O. Box 4000, Princeton, NJ 08543-4000, United States (US)
Inventor
- Name:
- BECHTOLD Clifford, M.
- Address:
- United States (US)
Priority
- Priority Number:
- 316745 P
- Priority Date:
- 31/08/2001
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/7072;
| Filing date | Document type | Number of pages |
|---|